Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 6 de 6
Filter
1.
Arch Soc Esp Oftalmol ; 85(7): 232-8, 2010 Jul.
Article in Spanish | MEDLINE | ID: mdl-21093712

ABSTRACT

OBJECTIVE: The aim of the study is to present the results of the first year of using a non-mydriatic fundus camera. We performed an evaluation of its usefulness and problems. METHODS: During the first year of using the non-mydriatic fundus camera we evaluated 3,272 type II diabetic patients who were not being controlled in the hospital. RESULTS: The diabetic retinopathy was observed in 164 patients (5.01%), the mild form in 70 patients (2.14%). Diabetic macular oedema was observed in 41 patients (1.25%). In 119 patients (3.63%) the retinography could not be interpreted and were referred to the hospital; 113 patients also were referred due to other pathologies; the largest group of these patients had age-related macular disease or age-related macular degeneration (42 patients). Finally, 458 patients (13.99%) required mydriatic eye-drops. CONCLUSIONS: The non-mydriatic fundus camera is a useful technique for assessing the presence of diabetic retinopathy, particularly in patients with poor ophthalmic control. This technique may enable us to diagnose these patients who need laser treatment.


Subject(s)
Diabetic Retinopathy/pathology , Adult , Aged , Aged, 80 and over , Diagnostic Techniques, Ophthalmological/instrumentation , Female , Humans , Male , Middle Aged , Spain
2.
Arch. Soc. Esp. Oftalmol ; 85(7): 232-238, jul. 2010. tab
Article in Spanish | IBECS | ID: ibc-84224

ABSTRACT

ObjetivoPresentar los resultados tras el primer año de funcionamiento de la cámara no midriática en nuestra área, evaluando su utilidad y los problemas que hemos observado.MétodosDurante el periodo de un año se han revisado 3.272 pacientes diabéticos tipo 2 mediante la cámara no midiátrica; estos pacientes no estaban siendo sometidos a controles periódicos en nuestro centro en razón a su patología ocular.ResultadosLa retinopatía diabética se observó en 164 pacientes (5,01%), la forma leve en 70 pacientes (2,14%). El edema macular diabético se apreció en 41 pacientes un 1,25%. En 119 (3,63%) pacientes no se pudo interpretar la imagen debiendo ser referidos a las consultas de oftalmología, además se derivaron 113 pacientes sin retinopatía diabética, de estos la mayoría (42 pacientes) presentaban lesiones en el área macular sospechosas de maculopatía o degeneración macular asociada a la edad. Finalmente en 458 (13,99%) pacientes se precisó la instilación de colirio midriático.ConclusionesPodemos extraer que el screening mediante cámara no midiátrica, es altamente útil para poder acceder a una gran parte de la población diabética, en especial aquella que acude con escasa frecuencia al oftalmólogo, permitiéndonos diagnosticar un número importante de pacientes susceptibles de tratamiento láser para evitar su ceguera(AU)


ObjectiveThe aim of the study is to present the results of the first year of using a non-mydriatic fundus camera. We performed an evaluation of its usefulness and problems.MethodsDuring the first year of using the non-mydriatic fundus camera we evaluated 3,272 type II diabetic patients who were not being controlled in the hospital.ResultsThe diabetic retinopathy was observed in 164 patients (5.01%), the mild form in 70 patients (2.14%). Diabetic macular oedema was observed in 41 patients (1.25%). In 119 patients (3.63%) the retinography could not be interpreted and were referred to the hospital; 113 patients also were referred due to other pathologies; the largest group of these patients had age-related macular disease or age-related macular degeneration (42 patients). Finally, 458 patients (13.99%) required mydriatic eye-drops.ConclusionsThe non-mydriatic fundus camera is a useful technique for assessing the presence of diabetic retinopathy, particularly in patients with poor ophthalmic control. This technique may enable us to diagnose these patients who need laser treatment(AU)


Subject(s)
Humans , Diabetic Retinopathy/epidemiology , Macular Degeneration/epidemiology , Mass Screening , Mydriatics/therapeutic use , Laser Therapy , Evaluation of Results of Preventive Actions
3.
Arch Soc Esp Oftalmol ; 83(10): 615-8, 2008 Oct.
Article in Spanish | MEDLINE | ID: mdl-18855282

ABSTRACT

CASE REPORT: We describe the case of a patient who presented with progressive and bilateral loss of vision. She had been treated with tamoxifen for 13 years. We performed fluorescein angiography and optical coherence tomography in order to study the macula. DISCUSSION: Loss of visual acuity related to tamoxifen maculopathy may be caused either by retinal nerve fibre atrophy or macular oedema. Macular findings obtained by fluorescein angiography and optical coherence tomography are complementary.


Subject(s)
Antineoplastic Agents, Hormonal/adverse effects , Retinal Diseases/chemically induced , Retinal Diseases/diagnosis , Tamoxifen/adverse effects , Tomography, Optical Coherence , Female , Humans , Middle Aged
4.
Arch. Soc. Esp. Oftalmol ; 83(10): 615-618, oct. 2008. ilus
Article in Es | IBECS | ID: ibc-68077

ABSTRACT

Caso clínico: Se describe el caso de una paciente que acudió por pérdida bilateral y progresiva de la visión después de haber recibido tratamiento con tamoxifeno durante 13 años. Para el estudio detallado de las alteraciones maculares se realizaron la angiografía fluoresceínica y la tomografía de coherencia óptica. Discusión: La pérdida de visión debido a la maculopatía por tamoxifeno puede ser debida tanto a la atrofia de las capas de fibras nerviosas de la retina como a la presencia de edema macular. Los hallazgos maculares obtenidos mediante la angiografía fluoresceínica y la tomografía de coherencia óptica son complementarios


Case report: We describe the case of a patient who presented with progressive and bilateral loss of vision. She had been treated with tamoxifen for 13 years. We performed fluoresce in angiography and optical coherence tomography in order to study the macula. Discussion: Loss of visual acuity related to tamoxifen maculopathy may be caused either by retinal nerve fibre atrophy or macular o edema. Macular findings obtained by fluorescein angiography and optical coherence tomography are complementary


Subject(s)
Humans , Female , Middle Aged , Tamoxifen/adverse effects , Tomography, Optical Coherence/methods , Macular Degeneration/chemically induced , Macular Degeneration/complications , Fluorescein Angiography/methods , Diagnosis, Differential , Tomography, Optical Coherence/trends , Tomography, Optical Coherence , Macular Degeneration/physiopathology , Macular Degeneration/therapy , Macular Degeneration
5.
Arch Soc Esp Oftalmol ; 82(4): 209-18, 2007 Apr.
Article in Spanish | MEDLINE | ID: mdl-17443425

ABSTRACT

OBJECTIVE: The aim of the study was to compare the results with those of a previous study by the same author in 1993 when 741 type II diabetic patients were recruited. We determined the prevalence of diabetic retinopathy and the impact of the new diagnostic criteria and stricter control of diabetes on the results obtained. METHODS: The study sample was obtained by hazard selection of 741 type II diabetic patients, from the total diabetic patients visited in the interval between January 1 and December 1 in 2005. RESULTS: We observed a decrease in the prevalence of diabetic retinopathy between the two studies. In the first study the incidence was 39.41% while in the present study it was 27.55%. The diabetic macular edema prevalence was similar in both studies (7.15% in the past and 7.90% in the present study). There was also a decrease in the number of blind patients (11.20% in 1993 and 4.90% in the current study). The number of patients treated with laser photocoagulation increased (13.49% in the current study as compared to 6.20% in the previous study). Statistic analysis revealed the risk factors for retinopathy: diabetes mellitus duration, elevated HbA1C levels and the need for insulin treatment. CONCLUSIONS: A better control of diabetes mellitus may lead us to observe an increase in visual acuity, and a better control of diabetic retinopathy. The incidence of diabetic retinopathy certainly decreased between the study periods; however the overall incidence of diabetes in the community has increased during the last few years, making firm conclusions difficult.


Subject(s)
Diabetic Retinopathy/epidemiology , Aged , Blood Glucose/analysis , Cross-Sectional Studies , Diabetes Mellitus, Type 2/blood , Diabetes Mellitus, Type 2/diagnosis , Diabetes Mellitus, Type 2/drug therapy , Diabetes Mellitus, Type 2/epidemiology , Diabetic Retinopathy/therapy , Female , Glycated Hemoglobin/analysis , Humans , Hypertension/epidemiology , Hypoglycemic Agents/therapeutic use , Incidence , Insulin/therapeutic use , Laser Coagulation , Male , Middle Aged , Papilledema/epidemiology , Papilledema/etiology , Prevalence , Severity of Illness Index , Spain/epidemiology , Visual Acuity
6.
Arch. Soc. Esp. Oftalmol ; 82(4): 209-218, abr. 2007. tab
Article in Es | IBECS | ID: ibc-054903

ABSTRACT

Objetivo: Comparar los resultados obtenidos en una muestra de población de 741 pacientes diabéticos tipo II en el año 1993 con una muestra actual de 741 pacientes diabéticos tipo II, determinando la prevalencia de retinopatía diabética, y valorando el impacto sobre la misma de los nuevos criterios diagnósticos y el mayor control de los pacientes diabéticos. Métodos: Estudio transversal en el que la muestra fue recogida mediante selección al azar de 741 pacientes afectos de diabetes mellitus tipo II del total del archivo de pacientes visitados regularmente a lo largo del período comprendido entre el 1 de enero y el 31 de diciembre del año 2005. Resultados: Se observa un descenso de prevalencia de retinopatía diabética del 39,41% en el primer estudio al 27,55% actual, manteniéndose igual el edema macular (7,15% en el primer estudio y 7,90% en el actual). Se ha observado un descenso en el número de pacientes ciegos, de un 11,20% a un 4,90%. Asimismo los pacientes tratados previamente con fotocoagulación láser aumentaron en el estudio actual, un 13,49% frente a un 6,20%. En el estudio estadístico los factores de riesgo son: el tiempo de evolución de la diabetes, el tratamiento con insulina de la misma, y los niveles elevados de HbA1c. Conclusiones: El mayor control ejercido sobre los pacientes diabéticos nos permite observar una mejoría en la agudeza visual. Observándose también que aumenta el número de pacientes tratados. Por otro lado al existir un mayor número de pacientes diabéticos conocidos, se produce un efecto de disminución de la prevalencia de la retinopatía


Objective: The aim of the study was to compare the results with those of a previous study by the same author in 1993 when 741 type II diabetic patients were recruited. We determined the prevalence of diabetic retinopathy and the impact of the new diagnostic criteria and stricter control of diabetes on the results obtained. Methods: The study sample was obtained by hazard selection of 741 type II diabetic patients, from the total diabetic patients visited in the interval between January 1 and December 1 in 2005. Results: We observed a decrease in the prevalence of diabetic retinopathy between the two studies. In the first study the incidence was 39.41% while in the present study it was 27.55%. The diabetic macular edema prevalence was similar in both studies (7.15% in the past and 7.90% in the present study). There was also a decrease in the number of blind patients (11.20% in 1993 and 4.90% in the current study). The number of patients treated with laser photocoagulation increased (13.49% in the current study as compared to 6.20% in the previous study). Statistic analysis revealed the risk factors for retinopathy: diabetes mellitus duration, elevated HbA1C levels and the need for insulin treatment. Conclusions: A better control of diabetes mellitus may lead us to observe an increase in visual acuity, and a better control of diabetic retinopathy. The incidence of diabetic retinopathy certainly decreased between the study periods; however the overall incidence of diabetes in the community has increased during the last few years, making firm conclusions difficult


Objetivo: Comparar los resultados obtenidos en una muestra de población de 741 pacientes diabéticos tipo II en el año 1993 con una muestra actual de 741 pacientes diabéticos tipo II, determinando la prevalencia de retinopatía diabética, y valorando el impacto sobre la misma de los nuevos criterios diagnósticos y el mayor control de los pacientes diabéticos. Métodos: Estudio transversal en el que la muestra fue recogida mediante selección al azar de 741 pacientes afectos de diabetes mellitus tipo II del total del archivo de pacientes visitados regularmente a lo largo del período comprendido entre el 1 de enero y el 31 de diciembre del año 2005. Resultados: Se observa un descenso de prevalencia de retinopatía diabética del 39,41% en el primer estudio al 27,55% actual, manteniéndose igual el edema macular (7,15% en el primer estudio y 7,90% en el actual). Se ha observado un descenso en el número de pacientes ciegos, de un 11,20% a un 4,90%. Asimismo los pacientes tratados previamente con fotocoagulación láser aumentaron en el estudio actual, un 13,49% frente a un 6,20%. En el estudio estadístico los factores de riesgo son: el tiempo de evolución de la diabetes, el tratamiento con insulina de la misma, y los niveles elevados de HbA1c. Conclusiones: El mayor control ejercido sobre los pacientes diabéticos nos permite observar una mejoría en la agudeza visual. Observándose también que aumenta el número de pacientes tratados. Por otro lado al existir un mayor número de pacientes diabéticos conocidos, se produce un efecto de disminución de la prevalencia de la retinopatía


Subject(s)
Male , Female , Humans , Diabetic Retinopathy/diagnosis , Diabetic Retinopathy/epidemiology , Cross-Sectional Studies , Light Coagulation/methods , Light Coagulation/trends , Risk Factors , Logistic Models , Macular Degeneration/complications , Macular Edema , Patient Selection , Lasers/therapeutic use , Multivariate Analysis , Diabetes Mellitus, Type 2/complications , Diabetes Mellitus, Type 2/diagnosis
SELECTION OF CITATIONS
SEARCH DETAIL
...